title: The role of cytoreductive surgery in advanced-stage ovarian cancer: a systematic review.
abstract: It has already been proven that ovarian cancer is the sixth most common cancer among women, and it is considered the leading cause of death by gynecologic cancer in developed countries. This article is a literature review based on the use of cytoreductive surgery matched with adjuvant chemotherapy in advanced-stage ovarian cancer. According to the statistics, the difficulty of obtaining an early diagnosis results in a delay in the disease treatment and as a consequence, in many cases, ovarian cancer is still diagnosed in the advanced stage of the disease. Primary surgery is performed, in addition to diagnosis and staging, to achieve optimal cytoreduction. The purpose of this article is to review the different surgical approaches in the management of epithelial ovarian cancer, specifically the high-stage disease, with a special concentration on the most recent therapeutic additions to our current knowledge, such as hyperthermic intraperitoneal chemotherapy and new therapeutic drugs. Surgical treatment still plays a pivotal role in the management of advanced-stage ovarian cancer. Complete cytoreduction continues to be, when feasible, the objective to be attempted in the surgical treatment of advanced ovarian cancer. Obviously, the success of the operation depends on numerous factors, including patient selection, the locations of tumors, and surgeon expertise. To offer patients the best possible outcome with the least accompanying morbidity, strong consideration should be given to the referral of such patients to expert care centers for primary surgery, because it may be the best means currently available for improving overall survival.
authors: Department of Obstetrics and Gynecology and Radiological Sciences, Gynecology and Obstetrics Unit, University of Catania, Catania, Italy, vitalesalvatore@hotmail.com.
authors: Salvatore Giovanni
authors: SG
authors: Vitale
authors: Ilaria
authors: I
authors: Marilli
authors: Melissa
authors: M
authors: Lodato
authors: Alessandro
authors: A
authors: Tropea
authors: Antonio
authors: A
authors: Cianci
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D000077216:Carcinoma, Ovarian Epithelial; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D009375:Neoplasms, Glandular and Epithelial / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery*; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery*
chemical_list: D000970:Antineoplastic Agents
references: Curr Treat Options Oncol. 2001 Apr;2(2):109-18
references: 12057129
references: J Clin Oncol. 2002 Mar 1;20(5):1248-59
references: 11870167
references: Gynecol Oncol. 2009 Jul;114(1):26-31
references: 19395008
references: Cochrane Database Syst Rev. 2011 Aug 10;(8):CD007565
references: 21833960
references: Gynecol Oncol. 2010 Mar;116(3):351-7
references: 20022092
references: Eur J Surg Oncol. 2009 Feb;35(2):135-43
references: 18289825
references: Gynecol Oncol. 2004 Nov;95(2):377-83
references: 15491760
references: CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
references: 20610543
references: J Clin Oncol. 2004 Apr 1;22(7):1315-27
references: 15051780
references: J Reprod Med. 2005 Jun;50(6):426-38
references: 16050567
references: Eur J Cancer. 2011 Sep;47 Suppl 3:S88-92
references: 21944035
references: Cancer. 2006 May 1;106(9):1933-9
references: 16572412
references: J Obstet Gynaecol Res. 2006 Dec;32(6):580-7
references: 17100820
references: Am J Obstet Gynecol. 1994 Apr;170(4):974-9; discussion 979-80
references: 8166218
references: Obstet Gynecol. 2006 Jun;107(6):1399-410
references: 16738170
references: J Cancer Res Clin Oncol. 2009 Dec;135(12):1637-45
references: 19701772
references: N Engl J Med. 2011 Dec 29;365(26):2484-96
references: 22204725
references: J Clin Oncol. 2005 Dec 1;23(34):8802-11
references: 16314640
references: Natl Cancer Inst Monogr. 1975 Oct;42:101-4
references: 1234624
references: Chin J Cancer Res. 2012 Dec;24(4):304-9
references: 23358672
references: Gynecol Oncol. 2012 Aug;126(2):220-3
references: 22555105
references: Semin Surg Oncol. 2000 Jul-Aug;19(1):42-8
references: 10883023
references: Semin Oncol. 2006 Apr;33(2 Suppl 6):S3-11
references: 16716797
references: Ann Surg Oncol. 2012 Mar;19(3):959-65
references: 21994038